참고문헌
- Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S (2006). Neutrophil-gelatinaseassociated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol, 26, 287-92. https://doi.org/10.1159/000093961
- Bennett M, Dent CL, Ma Q, et al (2008). Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol, 3, 665-73. https://doi.org/10.2215/CJN.04010907
- Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92. https://doi.org/10.1056/NEJMoa050518
- Brawley OW (2011). Avoidable cancer deaths globally. CA Cancer J Clin, 61, 67-8. https://doi.org/10.3322/caac.20108
- Devarajan P (2008). Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury. Nephrol Dial Transplant, 23, 3737-43. https://doi.org/10.1093/ndt/gfn531
- Gaspari F, Cravedi P, Mandala M, et al (2010). Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract, 115, 154-60. https://doi.org/10.1159/000312879
- Haase M, Bellomo R, Devarajan P, et al (2009). Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis, 54, 1012-24. https://doi.org/10.1053/j.ajkd.2009.07.020
- Haase M, Haase-Fielitz A, Bellomo R, et al (2009). Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med, 37, 39-47. https://doi.org/10.1097/CCM.0b013e318193216f
- Haase M, Haase-Fielitz A, Bellomo R, Mertens PR (2011). Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol, 18, 11-8. https://doi.org/10.1097/MOH.0b013e3283411517
- Haase M, Mertens PR (2010). Urinary biomarkers--silver bullets to faster drug development and nephron protection. Nephrol Dial Transplant, 25, 3167-9. https://doi.org/10.1093/ndt/gfq504
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kos FT, Sendur MA, Aksoy S, et al (2013). Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy. Asian Pac J Cancer Prev, 14, 1111-4. https://doi.org/10.7314/APJCP.2013.14.2.1111
- Launay-Vacher V, Oudard S, Janus N, et al (2007). Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer, 110, 1376-84. https://doi.org/10.1002/cncr.22904
- Lichtman SM, Wildiers H, Launay-Vacher V, et al (2007). International society of geriatric oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer, 43, 14-34. https://doi.org/10.1016/j.ejca.2006.11.004
- Lin HY, Lee SC, Lin SF, et al (2013). Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatininduced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J Med Sci, 29, 304-11. https://doi.org/10.1016/j.kjms.2012.10.004
- Ling W, Zhaohui N, Ben H, et al (2008). Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract, 108, 176-81. https://doi.org/10.1159/000117814
- Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S (2009). Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail, 31, 910-9. https://doi.org/10.3109/08860220903216113
- Mishra J, Dent C, Tarabishi R, et al (2005). Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet, 365, 1231-8. https://doi.org/10.1016/S0140-6736(05)74811-X
- Mishra J, Ma Q, Prada A, et al (2003). Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol, 14, 2534-43. https://doi.org/10.1097/01.ASN.0000088027.54400.C6
- Mishra J, Mori K, Ma Q, et al (2004). Neutrophil gelatinaseassociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol, 24, 307-15. https://doi.org/10.1159/000078452
- Nickolas TL, Barasch J, Devarajan P (2008). Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens, 17, 127-32. https://doi.org/10.1097/MNH.0b013e3282f4e525
- Parikh CR, Devarajan P (2008). New biomarkers of acute kidney injury. Crit Care Med, 36, 159-65. https://doi.org/10.1097/01.CCM.0000297875.55969.DB
- Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
- Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009). Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol, 27, 2758-65. https://doi.org/10.1200/JCO.2008.20.8983
- Wagener G, Jan M, Kim M, et al (2006). Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology, 105, 485-91. https://doi.org/10.1097/00000542-200609000-00011
피인용 문헌
- Differences in acute kidney injury ascertainment for clinical and preclinical studies vol.32, pp.11, 2017, https://doi.org/10.1093/ndt/gfx002
- Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury vol.40, pp.11, 2017, https://doi.org/10.1007/s40264-017-0565-7
- Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy vol.64, pp.10, 2017, https://doi.org/10.1002/pbc.26538
- Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy vol.243, pp.3, 2018, https://doi.org/10.1177/1535370217745302
- Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C vol.11, pp.4, 2018, https://doi.org/10.1111/cts.12547